MEDICAID—D. MD.: CMS DEFINITION OF ‘LINE EXTENSION’ UNDER MDRP PASSES MUSTER
(C.C.H.)
•
By Patricia K. Ruiz, J.D.
•
Copyright (c) CCH INCORPORATED, A Wolters Kluwer business. All rights reserved.
•
Health Law Daily Wrap Up
•
News: Story
Wolters Kluwer Health Law Daily
•
April 06, 2023
The court emphasized that CMS is not responsible for manufacturers' reliance on proposed regulations that were ultimately not adopted.
Vanda Pharmaceuticals, Inc. failed to show that CMS's final rule interpreting the “line extension” provision of the...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.